Compare MICC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MICC | RGEN |
|---|---|---|
| Founded | 2025 | 1981 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1B | 11.0B |
| IPO Year | 2025 | 1995 |
| Metric | MICC | RGEN |
|---|---|---|
| Price | $19.29 | $173.92 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 22 |
| Target Price | $19.08 | ★ $201.45 |
| AVG Volume (30 Days) | 725.1K | ★ 1.1M |
| Earning Date | 10-30-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | N/A | ★ 0.24 |
| Revenue | N/A | ★ $141,236,000.00 |
| Revenue This Year | $5.51 | $13.28 |
| Revenue Next Year | $4.03 | $29.14 |
| P/E Ratio | ★ $28.55 | $743.71 |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $12.94 | $100.99 |
| 52 Week High | $20.69 | $198.87 |
| Indicator | MICC | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 58.32 | 47.72 |
| Support Level | $18.83 | $158.62 |
| Resistance Level | $19.92 | $187.36 |
| Average True Range (ATR) | 0.35 | 8.14 |
| MACD | 0.20 | -0.41 |
| Stochastic Oscillator | 83.30 | 61.26 |
The Magnum Ice Cream Company is a spinoff from Unilever, a pure-play company in manufacturing and selling a broad portfolio of ice-cream brands. The company is a global category leader, operating in 80 countries with around 21% market share. TMICC owns four of the world's five largest ice-cream brands: the Heartbrand (an "umbrella" brand with numerous well-known subbrands, which constitutes around 35% of sales), Magnum (23%), Ben & Jerry's (14%), and Cornetto (9%). The business generates about 65% of its revenue in developed markets, with the balance coming from emerging markets.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.